Uncategorized Archives - Page 45 of 251

TuesdayMay 03, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Update on its Patented DehydraTECH(TM) Technology, Including the Approval of New Patent

Lexaria received its 25th patent – and the first patent for the use of DehydraTECH technology in the enhanced delivery of antiviral drugs The company is seeking IND approval from the FDA and has commenced its human HYPER-H21-4 study for hypertension with DehydraTECH-CBD, with results expected in Q3 2022 Lexaria is also commencing its human oral nicotine study, NIC-H22-1 to compare Lexaria's DehydraTECH-nicotine pouch performance to that of existing leading brands currently sold in the US such as ON! and Zyn Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced some positive news that further promotes…

MondayMay 02, 2022 9:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Strengthens Financial Profile with Debt Reduction, Adjustments to Revenue Strategy

Red White & Bloom Brands is a multi-state cannabis operator based in Canada and focused on developing revenue opportunities in strong U.S. cannabis markets such as Michigan, Florida and California The company recently announced it has eliminated $115 million in debt liabilities as part of its efforts to streamline its financial operations during a period when many companies are struggling with the effects of the COVID pandemic Red White & Bloom’s debt reduction includes cutting over $22 million in annual expenses The company has solidified its foothold in Michigan with acquisitions that have allowed it to become vertically integrated and…

FridayApr 29, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands its Patent Portfolio With New Patent for Antiviral Drug Delivery with DehydraTECH

Lexaria just received another patent for DehydraTECH(TM): this time for the enhanced delivery of antiviral drugs This becomes the company’s 25th patent granted worldwide and the 10th granted in the U.S. It adds to the company’s growing patent portfolio, which also consists of ~50 pending patents worldwide Over the 2022 calendar year, the company seeks to also pursue regulatory and commercial advancement In 2016, Lexaria Bioscience (NASDAQ: LEXX) received its first United States patent grant and over the years, the company has been aggressive at broadening its patent suite, a move which it has attributed to refining the patent claims…

FridayApr 29, 2022 9:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Extends Michigan Expansion with Debut of Platinum Vape Live Resin; Announces Plans to Release Full-Year 2021 Results on May 2

Red White & Bloom and its wholly owned subsidiary RWB Michigan LLC recently announced the rollout of Platinum Vape(TM) Live Resin in Michigan The debut marks the company’s entry into the live resin in Michigan, which yield higher margins than the company’s existing distillate vape products RWB expects to release its full-year 2021 results on May 2, with the management hosting a conference call on May 3 Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator on a mission to become the most recognizable cannabis company in the United States, is celebrating the fulfillment of its…

WednesdayApr 27, 2022 9:30 am

O’Cannabiz Conference Expo & Awards to Boost Local Cannabis Trade and Networking

Explore the world of cannabis and navigate the immense networking opportunities offered at the O’Cannabiz Conference Expo & Awards from June 1-3, 2022. This event offers a phenomenal stage for traders, cultivators, marketers, regulators, researchers, and cannabis businesses in the region to get recognition on the global forum, amongst the stalwarts of the cannabis space. This year, the conference is being organized by O’Cannabiz Conference Expo & Awards as a physical event at the International Centre- Hall#5, Ontario, Canada, after being canceled last year due to COVID-19. The Conference and Expo will be held at the 50,000 sq. ft hall…

WednesdayApr 27, 2022 9:30 am

Lift&Co. Expo Toronto 2022 – Lift Cannabis Business Conference To Offer Important Learning and Networking Sessions

Become a part of Canada’s #1 Cannabis Conference and Trade Show for a full-day immersive learning experience about Cannabis business and trade at the Lift Cannabis Business Conference on May 12, 2022. The business conference is a part of the 4-day Lift&Co. Expo Toronto 2022 that is being held at the Metro Toronto Convention Centre. The Cannabis Business Conference will be attended by cannabis business leaders from across North America and around the world and will feature speaker sessions and presentations to impart the latest intelligence on myriad aspects of the cannabis industry. Connect with the experts, innovators, regulators, and…

WednesdayApr 27, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches Fourth Human Study for Reducing Hypertension, Reports Positive Outcome of Third Human Study’s Data

Global drug delivery innovator Lexaria Bioscience is researching the ability of its patented DehydraTECH(TM) technology to improve the performance of a number of prescription drugs Lexaria is a world leader in the investigation of a DehydraTECH-processed cannabidiol (“CBD”) to potentially treat high blood pressure (hypertension), and study outcomes thus far have rendered positive results on effectiveness and patient tolerance The company is building a scorecard of data to support its planned FDA application for formal, registered clinical testing under the Investigational New Drug (“IND”) process Lexaria recently completed all data analyses of its HYPER-H21-3 study examining DehydraTECH-CBD’s ability to reduce…

MondayApr 25, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advancing DehydraTECH-Nicotine Research to Support Safer, More Effective Oral Alternative to Harmful Pulmonary Administration Practices

Lexaria expects to begin dosing this summer as part of a human nicotine study, NIC-H22-1, to compare DehydraTECH-nicotine pouch performance to that of existing leading brands such as ON! and Zyn So far, the company’s animal studies have evidenced that the technology delivers outstanding results, including faster delivery, an increase in the quantity of peak nicotine delivered, higher brain levels of nicotine, and enhanced bioavailability In its most recent study, Lexaria established that DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls and peak levels achieved were up to 10x higher than controls Lexaria’s research aims to…

FridayApr 22, 2022 9:00 am

Hero Technologies Inc. (HENC) Looks to Expand as States Report $3.7B in Cannabis Recreational Tax Revenue in 2021

MPP report notes that states with legalized marijuana for adult use generated $3.7 billion in tax revenue from recreational cannabis sales HENC is looking to leverage its cannabis expertise in more of these states Company is aggressively pursuing expansion into Colorado, Massachusetts A new report reveals that states with legalized recreational marijuana collected an estimated $3.7 billion in tax revenues last year (https://cnw.fm/xP9p5). That news bodes well for savvy players in the legal cannabis space, including Hero Technologies (OTC: HENC), as states are often eager to support revenue sources. “States that have legalized marijuana for adult use collectively generated more than…

ThursdayApr 21, 2022 9:30 am

The Southeastern Hemp & Medical Cannabis Convention, Helping to Shape The Future Of The Industry

Cannabis growers, traders, businesses, researchers, processors, testing laboratory personnel, facility management, and investors, are all invited to attend the SHMC (Southeastern Hemp & Medical Cannabis) Convention being held from the 12th to the 14th of May, 2022, at the Cobb Galleria Centre, Two Galleria Parkway, Atlanta, Georgia. The event, also to be streamed online for worldwide access, is organized by Organa Kannalytics LLC. The SHMC offers a robust platform for startups and industries to identify novel avenues of growth in this dynamic and budding industry. This convention attracts a vast profile of attendees from varied industry verticals seeking investment and business…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized